Skip to main content

Remote Job Finders (RJF)

IRA’s Definition of ‘Drug’ Creates Confusion for Developers

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price negotiation purposes—even if approved by the FDA under a separate application—disincentivizing companies from investing time and money in gaining approval for new formulations and indications.

AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D

Pascal Soriot’s comments came during AstraZeneca’s Q2 earnings call in regard to President Donald Trump’s newly announced European pharma tariffs. The company also announced estimate-beating earnings, with its cancer portfolio driving earnings despite clinical roadblocks.

Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%

In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its semaglutide franchise in the U.S.—and named current international operations head Maziar Mike Doustdar as its new president and CEO.
Scroll to top